205 related articles for article (PubMed ID: 12659668)
1. Vitamin D binding protein-macrophage activating factor (DBP-maf) inhibits angiogenesis and tumor growth in mice.
Kisker O; Onizuka S; Becker CM; Fannon M; Flynn E; D'Amato R; Zetter B; Folkman J; Ray R; Swamy N; Pirie-Shepherd S
Neoplasia; 2003; 5(1):32-40. PubMed ID: 12659668
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D binding protein-macrophage activating factor inhibits HCC in SCID mice.
Nonaka K; Onizuka S; Ishibashi H; Uto Y; Hori H; Nakayama T; Matsuura N; Kanematsu T; Fujioka H
J Surg Res; 2012 Jan; 172(1):116-22. PubMed ID: 20855083
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of angiogenesis by vitamin D-binding protein: characterization of anti-endothelial activity of DBP-maf.
Kalkunte S; Brard L; Granai CO; Swamy N
Angiogenesis; 2005; 8(4):349-60. PubMed ID: 16400520
[TBL] [Abstract][Full Text] [Related]
4. The effects of vitamin D binding protein-macrophage activating factor and colony-stimulating factor-1 on hematopoietic cells in normal and osteopetrotic rats.
Benis KA; Schneider GB
Blood; 1996 Oct; 88(8):2898-905. PubMed ID: 8874186
[TBL] [Abstract][Full Text] [Related]
5. Pancreatic carcinogenesis: apoptosis and angiogenesis.
Onizuka S; Kawakami S; Taniguchi K; Fujioka H; Miyashita K
Pancreas; 2004 Apr; 28(3):317-9. PubMed ID: 15084979
[TBL] [Abstract][Full Text] [Related]
6. The anabolic effects of vitamin D-binding protein-macrophage activating factor (DBP-MAF) and a novel small peptide on bone.
Schneider GB; Grecco KJ; Safadi FF; Popoff SN
Crit Rev Eukaryot Gene Expr; 2003; 13(2-4):277-84. PubMed ID: 14696974
[TBL] [Abstract][Full Text] [Related]
7. Effects of vitamin D-binding protein-derived macrophage-activating factor on human breast cancer cells.
Pacini S; Punzi T; Morucci G; Gulisano M; Ruggiero M
Anticancer Res; 2012 Jan; 32(1):45-52. PubMed ID: 22213287
[TBL] [Abstract][Full Text] [Related]
8. Generation of multiple angiogenesis inhibitors by human pancreatic cancer.
Kisker O; Onizuka S; Banyard J; Komiyama T; Becker CM; Achilles EG; Barnes CM; O'Reilly MS; Folkman J; Pirie-Shepherd SR
Cancer Res; 2001 Oct; 61(19):7298-304. PubMed ID: 11585769
[TBL] [Abstract][Full Text] [Related]
9. Immunotherapy of BALB/c mice bearing Ehrlich ascites tumor with vitamin D-binding protein-derived macrophage activating factor.
Yamamoto N; Naraparaju VR
Cancer Res; 1997 Jun; 57(11):2187-92. PubMed ID: 9187119
[TBL] [Abstract][Full Text] [Related]
10. Structurally well-defined macrophage activating factor derived from vitamin D3-binding protein has a potent adjuvant activity for immunization.
Yamamoto N; Naraparaju VR
Immunol Cell Biol; 1998 Jun; 76(3):237-44. PubMed ID: 9682967
[TBL] [Abstract][Full Text] [Related]
11. Effects of vitamin D binding protein-macrophage activating factor (DBP-MAF) infusion on bone resorption in two osteopetrotic mutations.
Schneider GB; Benis KA; Flay NW; Ireland RA; Popoff SN
Bone; 1995 Jun; 16(6):657-62. PubMed ID: 7669443
[TBL] [Abstract][Full Text] [Related]
12. Mitogen-activated protein kinase pathway mediates DBP-maf-induced apoptosis in RAW 264.7 macrophages.
Gumireddy K; Reddy CD; Swamy N
J Cell Biochem; 2003 Sep; 90(1):87-96. PubMed ID: 12938159
[TBL] [Abstract][Full Text] [Related]
13. Role of vitamin D3-binding protein in activation of mouse macrophages.
Yamamoto N; Naraparaju VR
J Immunol; 1996 Aug; 157(4):1744-9. PubMed ID: 8759764
[TBL] [Abstract][Full Text] [Related]
14. Baculovirus-expressed vitamin D-binding protein-macrophage activating factor (DBP-maf) activates osteoclasts and binding of 25-hydroxyvitamin D(3) does not influence this activity.
Swamy N; Ghosh S; Schneider GB; Ray R
J Cell Biochem; 2001; 81(3):535-46. PubMed ID: 11255236
[TBL] [Abstract][Full Text] [Related]
15. Conversion of vitamin D3 binding protein (group-specific component) to a macrophage activating factor by the stepwise action of beta-galactosidase of B cells and sialidase of T cells.
Yamamoto N; Kumashiro R
J Immunol; 1993 Sep; 151(5):2794-802. PubMed ID: 8360493
[TBL] [Abstract][Full Text] [Related]
16. IB05204, a dichloropyridodithienotriazine, inhibits angiogenesis in vitro and in vivo.
Martínez-Poveda B; Muñoz-Chápuli R; Rodríguez-Nieto S; Quintela JM; Fernández A; Medina MA; Quesada AR
Mol Cancer Ther; 2007 Oct; 6(10):2675-85. PubMed ID: 17938261
[TBL] [Abstract][Full Text] [Related]
17. Vitamin D binding protein-macrophage activating factor directly inhibits proliferation, migration, and uPAR expression of prostate cancer cells.
Gregory KJ; Zhao B; Bielenberg DR; Dridi S; Wu J; Jiang W; Huang B; Pirie-Shepherd S; Fannon M
PLoS One; 2010 Oct; 5(10):e13428. PubMed ID: 20976141
[TBL] [Abstract][Full Text] [Related]
18. Immunotherapy of metastatic colorectal cancer with vitamin D-binding protein-derived macrophage-activating factor, GcMAF.
Yamamoto N; Suyama H; Nakazato H; Yamamoto N; Koga Y
Cancer Immunol Immunother; 2008 Jul; 57(7):1007-16. PubMed ID: 18058096
[TBL] [Abstract][Full Text] [Related]
19. Effects of vitamin D(3)-binding protein-derived macrophage activating factor (GcMAF) on angiogenesis.
Kanda S; Mochizuki Y; Miyata Y; Kanetake H; Yamamoto N
J Natl Cancer Inst; 2002 Sep; 94(17):1311-9. PubMed ID: 12208896
[TBL] [Abstract][Full Text] [Related]
20. A novel assay system for macrophage-activating factor activity using a human U937 cell line.
Ishikawa M; Inoue T; Inui T; Kuchiike D; Kubo K; Uto Y; Nishikata T
Anticancer Res; 2014 Aug; 34(8):4577-81. PubMed ID: 25075102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
